Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIVINOSTAT vs GLATIRAMER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GIVINOSTAT vs GLATIRAMER: Safety Overview

Metric GIVINOSTAT GLATIRAMER
Total FAERS Reports 265 46,357
Deaths Reported 5 696
Death Rate 1.9% 1.5%
Hospitalizations 17 5,831
Average Patient Age 15.1 yrs 48.4 yrs
% Female Patients 0.4% 81.0%
FDA Approval Date Mar 21, 2024 Apr 16, 2015
Manufacturer Italfarmaco SPA Zydus Pharmaceuticals USA Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Discontinued